Reportlinker Adds Global Blood Banking and Blood Products Industry
NEW YORK, Oct. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Blood Banking and Blood Products Industry
http://www.reportlinker.com/p020749/Global-Blood-Banking-and-Blood-Products-Industry.html
This report analyzes the worldwide markets for Blood Banking & Blood Products in US$ Million by the following Product Segments: Blood Components and Plasma Products (Whole Blood & Cellular Components, & Plasma Fractions), and Equipment, Blood Tests and Other Consumables (Includes blood screening and related QC function, but excludes patient diagnosis). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets. The report profiles 205 companies, including leading blood banks such as AABB, America's Blood Centers, American Red Cross, Canadian Blood Services, CorCell Companies, Inc., Cord Blood Registry, Japan Red Cross, Lifebank Corp, National Blood Foundation, New England Cord Blood Bank, Inc., New York Blood Center, and VITA 34 AG. Some of the leading players in Blood Bank Technology & Supplies also discussed in this report include Beckman Coulter Inc., Becton Dickinson and Company, BioMerieux SA, Caridian BCT, Inc., Chiron, CSL Behring LLC, Daxor Corporation, Fenwal Inc., Fresenius SE, Gambro AB, Gen-Probe Incorporated, Haemonetics Corp, Hemagen Diagnostics Inc., Immucor Inc., Kawasumi Laboratories, Inc., Olympus America, Inc., PharmaStem Therapeutics, Inc., Terumo Corporation, ThermoGenesis Corp., and Velico Medical, Inc. Leading Players discussed under the Plasma Fractionation segment include Baxter International Inc., Bio Products Laboratory, CSL Limited, CSL Bioplasma, Grifols, Kedrion, Laboratorie Francais du Fractionnement et des Biotechnologies, Octapharma, Sanquin, and Talecris Biotherapeutics. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
BLOOD BANKING & BLOOD PRODUCTS MCP-1028
A GLOBAL STRATEGIC BUSINESS REPORT
CONTENTS
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Data Interpretation & Reporting Level 2
Quantitative Techniques & Analytics 3
Product Definitions and Scope of Study 3
Blood Components and Plasma Products 3
Whole Blood & Cellular Components 4
WBCs 4
RBCs 4
Platelets 4
Plasma Fractions 4
Fresh Frozen Plasma 4
Albumin Fractions 5
Factor VIII 5
Factor IX and Factor IX Complex 5
Fibrin/Thrombin 5
Equipment, Blood Tests and Consumables 5
Automated Analyzers for Blood Analysis 5
Blood Tests 6
Consumables 6
2. MARKET OVERVIEW 7
Healthcare Scares Propel the Market 7
Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts 7
Worldwide Blood Banking and Blood Products Market at a
Glance (All figures are 2010 estimates & CAGR is for the
period 2007-2015) 8
Current & Future Analysis 8
Analysis by Geographic Region 8
Analysis by Product Segment 9
World Blood Components and Plasma Market Analysis in Units 9
Table 1: World Recent Past, Current & Future Analysis for
Blood Components and Plasma by Region/Country - USA, Europe,
Japan, and Rest of World Markets Independently Analyzed with
Annual Consumption in Million Units for Years 2007 through
2015 (includes corresponding Graph/Chart) 10
Table 2: World 9-Year Perspective for Blood Components and
Plasma by Region/Country - Percentage Breakdown of Volume
Consumption for USA, Europe, Japan, and Rest of World Markets
for Years 2007, 2010 & 2015 (includes corresponding
Graph/Chart) 11
Red Blood Cells - A Key Blood Component and a Major Contributor 12
Table 3: World Recent Past, Current & Future Analysis for
Red Blood Cells by Region/Country - USA, Europe, Japan, and
Rest of World Markets Independently Analyzed with Annual
Consumption in Million Units for Years 2007 through 2015
(includes corresponding Graph/Chart) 12
Table 4: World 9-Year Perspective for Red Blood Cells by
Region/Country - Percentage Breakdown of Volume Consumption
for USA, Europe, Japan, and Rest of World Markets for Years
2007, 2010 & 2015 (includes corresponding Graph/Chart) 13
3. MARKET TRENDS & ISSUES 14
New Infections - A Continuous Threat 14
Safety and Availability: The Core Issues 14
Decontamination: A Viable Process 15
New Processes for Safer Blood Supply 15
Innovative Procedures Help Blood Conservation 15
Autologous Transfusion Strapping up for High Growth 15
Enzyme Converted Cells Set to Rule the Industry 16
Blood Unavailability: Substitutes to the Rescue 16
Transfusions: Hospitals Making Way for Others 16
Computer Identification Helps Patients 17
SARS: A Case of Mistaken Identity? 17
Pooling: Economical HIV Testing 17
Private Cord Blood Banking: Flying High Despite Opposition 17
Consolidation Whittles Down Number of Market Players 17
Table 5: Leading Players in the Global Blood Screening Market
(2008) (includes corresponding Graph/Chart) 18
Table 6: Leading Players in the Global Plasma Derived
Products Market (2008): Market Share in terms of Revenues for
Baxter, CSL, Octapharma, Talecris and Grifols (includes
corresponding Graph/Chart) 18
Table 7: Market Shares of CSL Behring and Talecris in Select
Plasma Product Markets in terms of Revenues (2008) (includes
corresponding Graph/Chart) 19
Automation of Blood Banking - Nearing the Efficiency Frontier? 19
Automated Instrumentation Taking the Front Seat 19
Table 8: World Market for Blood Bank Technology (2007):
Percentage Breakdown of Revenues by Segment - Manual Blood
Bag Systems, Automated Systems, Component Lab, Commercial
Plasma, Blood Salvage, and Pathogen Inactivation (includes
corresponding Graph/Chart) 20
Table 9: Leading Players in the World Market for Automated
Collection of Blood Components using Apheresis Technology
(2005 - A Historic Review): Percentage Breakdown of Revenues
for Gambro, Baxter, Haemonetics, Fresenius, and Others
(includes corresponding Graph/Chart) 20
Plasma Market: Automation Making Inroads 20
The RBC Market - Slow to Catch Up 20
Automation of Testing - Yet to Mature 21
Automation to Suffice Shortage Problems 21
How Near to the Efficiency Frontier? 21
4. PRODUCT OVERVIEW 22
Blood Banking and Blood Products Industry 22
Blood Components and Plasma Products 22
Equipment, Blood Tests and Consumables 22
Automated Analyzers for Blood Analysis 22
Blood Tests 22
Consumables 23
Blood Collection Equipment 23
Blood Collection Monitors 23
Blood Donor Couches 23
Blood Processing Equipment 23
Blood Bank Centrifuges 23
Plasma Thawing 23
Blood Cell Separators 24
Blood Storage Equipment 24
Blood Bags 24
Platelet Agitators 24
Blood Bank Refrigerators 24
Blood - A Primer 24
Ionic Structure 24
Blood Components and their Applications 25
Blood Constituents 26
Plasma 26
Red Blood Cells (RBC) 26
Blood Count 27
Platelets 27
Table 10: Platelets (Leucodepleted) Issued by Select Region/
Agency (2005) (includes corresponding Graph/Chart) 28
White Blood Cells (WBC) 28
Derivative Products of Blood or Plasma Fractions 29
Plasma Protein and Fractionation 29
The Need 29
Fresh Frozen Plasma 29
Other Plasma Fractions 30
Albumin Fractions 30
Albumin Usage Rising in Profile, Wastage Worries Run Deep 30
Immunoglobulins 30
Table 11: Leading Countries in IVIg Usage Rates in Grams per
1000 Population (includes corresponding Graph/Chart) 30
Hyper-Immune Immunoglobulin 31
Factor VIII 31
Table 12: Leading Players in World Market for Factor VIII
(2006): Percentage Breakdown of Revenues for Baxter, Bayer
(Kogenate), CSL Behring (Helixate) and Wyeth (includes
corresponding Graph/Chart) 31
Factor IX and Factor IX Complex 31
Fibrin/Thrombin 31
Consumption of Blood Based on Type of Surgery/ Accident (In
Units) 32
Table 13: World Market for Plasma Derivatives (2009):
Percentage Breakdown of Revenues by Region/Country - USA,
Europe, Asia-Pacific, Latin America, and Rest of World
(includes corresponding Graph/Chart) 32
Table 14: World Market for Plasma Derivatives (2006):
Percentage Breakdown of Revenues by Product Type - IVIg,
Factor VIII, Albumin, Hyperimmunes, Factor IX and Others
(includes corresponding Graph/Chart) 32
Table 15: Plasma Collection in Select Countries in Thousand
Liters (includes corresponding Graph/Chart) 33
Recombinant Products 33
Therapeutic Uses of Plasma Products 33
Albumin Products 34
Immunoglobulins 34
Intravenous Immunoglobulin (IVIg) 34
Normal Immunoglobulin (IMIg) 34
CMV Immunoglobulin 34
Hepatitis B Immunoglobulin 35
Rh (D) Immunoglobulin 35
Tetanus Immunoglobulin IM 35
Zoster Immunoglobulin 35
Plasma Derived Coagulant Products 35
Biostate® 35
Ceprotin® 35
Factor VII Concentrate 36
Factor XI Concentrates 36
Feiba VH® Inhibitor Treatment 36
Fibrogammin P® 36
Monofix®-VF 36
ProthrombinexTM-HT 36
Thrombotrol®-VF 36
5. BLOOD COLLECTION METHODS 37
Banking the Natural Blood Resources 37
Blood Banks 37
Blood Banking 37
Blood Transfusion 37
Role of Blood Banks 37
Blood Donor: The Epicenter of the Process 37
Eligibility Criteria for the Donor 38
The Basics of Blood Donation - Myths Exploded & Other Facts 38
Table 16: Active Donors of Whole Blood and Apheresis per
1,000 of Population by Country/Agency (includes
corresponding Graph/Chart) 39
Table 17: Percentage Breakdown of Apheresis and Whole Blood
Donations by Country (2005) (includes corresponding
Graph/Chart) 40
Collection Methods 40
Blood Donation: The Process 40
Types of Blood Donation 40
Directed Blood Donations 40
Autologous Blood Donation 41
Alternative Usage of Patient's Own Blood 41
General Blood Donation 41
Hemodilution 41
Wound Drainage 41
Cell Saver 41
The Method 42
Blood Salvaging 42
Blood Collection Centers 42
Blood Collection Management System 42
A Historical Retrospective 42
Blood Collection Centers 43
Types of Blood Collection Centers 43
Cord Blood Banks 43
Profit Collection Centers 43
Military Blood Banks 43
Hospital Blood Banks 43
Community Blood Banks 44
Non-Profit Collection Centers 44
Blood Processing 44
Blood Typing 45
Rh Blood Group System 45
ABO Blood Group System 45
Blood Types and their Compatibility 46
Table 18: Occurrence of Blood Groups Worldwide (In %)
(includes corresponding Graph/Chart) 46
Blood Test 46
Blood Culture 47
The Costs 47
History of Blood Banking 47
6. THE CHANGING LANDSCAPE OF TRANSFUSION TECHNOLOGIES & TESTS 50
Blood Transfusion: A Backdrop 50
Massive Transfusion 50
Complications and Risks Due to Transfusion 50
Circulatory Overload 51
Graft Versus Host Disease (GVHD) 51
Haemolytic Transfusion Reactions 51
Iron Overload 51
Bacterial Contamination 51
Thrombophlebitis 51
Allergic Reactions 52
Air Embolism 52
Hyperkalaemia 52
Changing Role of Blood Banking Technology 52
7. BLOOD TRANSFUSION: THE PROCESS, TESTS/TECHNOLOGIES 53
Cross Matching 53
Blood Donor/Recipient Screening 53
Blood Typing 53
Leukoreduction 53
Leukocyte Reduction Specification Standards/Filters 54
Coombs Test 54
8. ALTERNATIVES TO BLOOD TRANSFUSION: A REAL THREAT TO THE INDUSTRY 55
Bloodless Surgery 55
Therapeutic Apheresis 55
Plasmapheresis 55
Plateletpheresis 56
Leukapheresis 56
Volume Expanders 56
Colloids 56
Albumin 56
Dextrans 56
Hydroxyethyl Starch 57
Crystalloids 57
Blood Growth Factor Therapies - Newer Alternatives to Transfusion 57
9. BLOOD SUBSTITUTES 58
Blood Substitutes Under Development by Manufacturers 58
Synthetic Blood Manufacturers/Developers 59
Alliance Pharmaceuticals Corp. (USA) 59
Biopure Corporation (USA) 59
Enzon Pharmaceuticals (USA) 60
Hemosol Inc. (Canada) 60
Northfield Laboratories Inc. (USA) 60
Synthetic Blood International, Inc. (USA) 60
10. PRODUCT INTRODUCTIONS/INNOVATIONS 61
Fenwal Receives US FDA Clearance for Fenwal Amicus® Separator
System 61
FamilyCord Introduces New More Efficient and Safe Cord Blood
Collection Kit 61
BD Unveils BD Microtainer® MAP Microtube 61
Pall Releases Advanced Blood Filter 62
Fenwal Responds to Haemonetics' New Lawsuit Against Alyx® System 63
CaridianBCT Rolls Out RBCX Protocol 63
ITL Launches TEGO™ Animal Blood Collection Kit 64
Fenwal to Launch Modified ALYX Kit 64
QIAGEN Launches New QIAsafe DNA Blood Products 64
Gambro Introduces New Prismaflex eXeed™ System 65
AnaSpec Unveils 'SensoLyte® Rh110 Plasmin Activity Assay Kit 65
Typenex® Medical Rolls Out New Barcode Blood Band 66
Olympus Introduces Hemoglobin A1c APT Reagent for Chemistry
Analyzer System 66
BD Diagnostics Launches BD BACTEC™ FX Blood Culture System 66
Beckman Coulter Launches UniCel DxH 800 Coulter® Cellular
Analysis System 67
Diazyme Secures FDA Clearance for Marketing Liquid Stable
Enzymatic Lithium Test 68
ThermoGenesis Launches New Range of Veterinary POC Products 68
Prometheus Develops First Blood Test for IBS Diagnosis 69
CaridianBCT Introduces 'Atreus® 3C Whole Blood Processing
System' 69
GeneNews Unveils ColonSentry™ for Diagnosing Colorectal Cancer 69
Haemonetics Upgrades PCS®2 System with Quicker Plasma
Collection Software 70
11. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST - A PERSPECTIVE
BUILDER 71
Olympus Launches AU680® Chemistry Analyzer 71
Haemonetics Software Expands Symphony 2.0 Software with New
Module71Gen-Probe Introduces APTIMA® HPV Assay 71
Olympus Life Science Europa Introduces Automated HbA1c Assay 72
Haemonetics Unveils New Plasma Collection Software 72
Pall Unveils Acrodose™ PLus System 72
Z-Medica Rolls Out Rapid Blood Clotting Products in the
Consumer Market 72
Dade Behring Launches the Quadriga BeFree System 73
Swedish Inventors Develop New Processing System 73
Canada Invents New Method for Monitoring Blood and Blood Products 73
Terumo Launches Improvised Bags For Safe Blood Collection 73
Haemonetics Launches Cymbal Automated Blood Collection System 74
12. PRODUCT APPROVALS IN THE RECENT PAST 75
Cerus Receives CE Mark Approval for the Intercept Blood System
for Platelets 75
Haemonetics Wins FDA Approval for the ACP 215 System 75
Biomerieux' Polycarbonate BacT/ALERT Receives US FDA Clearance 75
Pall's eBDS Receives Green Signal from FDA 76
CardioPAT™ Surgical Blood Salvage System 76
PCS® 2 - Set to Enhance Plasma Quality 76
Dade Behring's D-Dimer Assay Strapping up for Roll Out 76
13. RECENT INDUSTRY ACTIVITY 77
HemaCare Signs Two New Blood Service Contracts 77
Cord Blood Acquires Majority Stake in Stellacure 77
Haemonetics Gains Rights to Alba's Full Line of Blood Typing
Reagents 78
ThermoGenesis Inks Deal with Fenwal and Enters Asian Markets 78
CaridianBCT Obtains FDA Approval for New 6.0 Trima Accel®
Automated Blood Collection System 79
American Red Cross Inks 3-Year Deal with ITL 79
FDA Grants 510(K) Clearance for Expanded Use of Haemonetics 80
ThermoGenesis and GE Healthcare Enter into Distribution Deal 80
Daxor's Idant Labs Bags Blood Banking Contract from RMSB&G 81
Beckman Coulter Agrees to Distribute CellaVision Digital
Morphology Products 81
Haemonetics to Acquire Global Med 82
Therapure Biopharma Inks Long Term Pact with LFB Biomedicaments 82
PathCare Establishes New Cord Blood Stem Cell Banking Facility 83
MRHC Obtains License for SafeTrace Tx Solution of Global Med 83
Life Technologies to Acquire AcroMetrix 83
Fenwal Secures FDA Approval for New Platelet Additive Solution 84
Daxor Sells Blood Volume Analyzer to MUSC 84
Heska Enters into a Supply Agreement with Roche Diagnostics 85
BLOOD Bank of Alaska Obtains License for Mediware's LifeTrak
Technology 85
Europe and the US Expand Blood Banking Agreement 86
Daxor to Provide BVA-100 Blood Volume Analyzer to Durham VA
Medical Center 86
Pfizer Acquires Wyeth 86
Baxter Inaugurates New BLOOD Plasma Fractionation Facility in
Vienna 87
ProMetic Acquires Majority Shareholding in PRDT 87
BD Diagnostics Bags FDA Approval for BD Vacutainer® Rapid
Serum Tube 87
Cadila to Establish Biosimilars Manufacturing Plant 88
China Biologic to Collaborate with IBT on Research & Development 88
Abbott Obtains FDA Approval for Abbott Prism HIV O Plus Test 88
Gen-Probe to Establish Independent New Firm for Industrial
Testing 89
Haemonetics Acquires SEBRA Blood Collection & Processing Unit 90
Beckman Coulter Acquires Lab-Based Diagnostics Business of
Olympus 91
Daxor to Provide BVA-100 Blood Volume Analyzer to Pacific
Cardiology 91
Golden Meditech and Fenwal to Establish a Blood Collection
Joint Venture in China 91
PRCS Inaugurates State-of-the-Art Blood Bank 92
CSL and Talecris Terminate Merger Agreement 92
Immucor Inks 5-Year Deal with Alverno 92
Gen-Probe Acquires Tepnel and Renews Partnership with Novartis 93
Haemonetics Takes Over Neoteric Technology 93
Haemonetics Acquires Altivation Software 94
PacifiCord Sets Up Cord Blood Banking Facility in Irvine 95
China Biologic Acquires 35% Stake in Xi'an Huitian Blood
Products 95
Biocell and Cellsense Merge 95
Octapharma Plans to Set Up Fractionation Facility 95
Therapure BioPharma Inks Development Services Deal with LFB
Biotechnologies 96
Strassenburg and CordLife to Establish Blood Banking Facility
in Kolkata, India 96
Biotest Acquires Blood Plasma Collection Center from Talecris 96
NCRM and Jeevan Stem Cell Bank Signs MoU for Cord Blood Stem
Cells Research 96
TCH of Tahlequah Acquires Daxor's BVA-100 Blood Volume Analyzer 97
Gen-Probe Expands and Extends Blood Screening Alliance with
Novartis 97
Celestial Biologicals Collaborates With GE Healthcare for
Indian Market 98
China Biologic to Purchase Stake in Dalin 98
Cerus Enters Into Deal with Fenwal 98
Bennnett, Coleman Picks Up Minority Stake in Stem One
Biologicals 99
Cryo-Cell Renews Exclusive Retailer Agreement with Upromise® 99
Pantheon China to Take Over China Cord Blood Services 99
United Blood Services to Divest Jackson Operations to
Mississippi Blood Services 100
ITL Signs Agreement with Blood Centers of America 100
CaridianBCT Mirasol PRT System Receives CE Mark Approval 100
CaridianBCT Signs Deal with American Red Cross for Automated
Blood Collection Technology 100
Genzyme Japan to Acquire Lymphoglobuline Marketing from CSL
Behring 101
Biotest Diagnostics and GSABC Ink a Deal 101
Blood Cell Storage Inks Option Agreement With CaridianBCT 102
CBB Inaugurates Donor Facility In Indio 102
CSL to Acquire Talecris 102
Novartis Diagnostics Gains FDA Clearance for PROCLEIX®
ULTRIO® Assay 103
ViaCord to Collaborate with Mia Hamm Foundation 103
Octapharma to Take Over Plasma Centers from International
BioResources 104
America's Blood Centers and MDA Ink a Contingency Deal 104
Piramal Healthcare Enters into an Agreement with PlasmaSelect 104
Grifols Secures Commercial Loan for Purchasing Plasma Centres 105
Cytori Inks Supplying Agreement with Biohellenika 105
Animal Blood Bank and Midwest Animal Blood Services Merge to
Form Animal Blood Resources 105
Gambro Gains FDA Approval for Sale of Atreus® 105
Cerus Signs Agreement for INTERCEPT Platelet System Supply 106
Haemonetics Teams Up with Octapharma for Plasma Collection
Technology 106
Gambro Inks Deal with S.C.M to Divest Its Bloodline
manufacturing Unit 106
Octapharma Acquires PVG 107
14. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER 108
15. FOCUS ON SELECT GLOBAL PLAYERS 139
Leading Blood Banks 139
AABB (USA) 139
America's Blood Centers (USA) 139
American Red Cross (USA) 139
Canadian Blood Services (Canada) 140
CorCell Companies Inc. (USA) 140
Cord Blood Registry (USA) 141
Japan Red Cross Society (Japan) 141
Lifebank Corp. (Canada) 141
National Blood Foundation (USA) 142
New England Cord Blood Bank, Inc. (USA) 142
New York Blood Center (USA) 142
VITA 34 AG (Germany) 143
Leading Players in Blood Bank Technology and Supplies 143
Beckman Coulter, Inc. (USA) 143
Becton, Dickinson and Company (USA) 143
BioMerieux SA (France) 143
Caridian BCT, Inc (USA) 144
Chiron (USA) 144
CSL Behring LLC (USA) 145
Daxor Corporation (USA) 145
Fenwal Inc., (USA) 145
Fresenius SE (Germany) 146
Gen-Probe, Inc. (USA) 146
Haemonetics Corp. (USA) 147
Hemagen Diagnostics Inc. (USA) 147
Immucor Inc. (USA) 147
Kawasumi Laboratories, Inc. (Japan) 148
PharmaStem Therapeutics, Inc. (USA) 148
Terumo Corp. (Japan) 149
ThermoGenesis Corp. (USA) 149
Velico Medical, Inc. (USA) 149
Leading Players in Plasma Fractionation 150
Baxter International Inc. (USA) 150
Bio Products Laboratory (UK) 150
CSL Limited (Australia) 150
CSL Bioplasma (Australia) 150
Grifols (Spain) 151
Kedrion (Italy) 151
Laboratoire Francais du Fractionnement et des Biotechnologies
(France) 151
Octapharma (Switzerland) 152
Sanquin (The Netherlands) 152
Talecris Biotherapeutics (USA) 152
16. GLOBAL MARKET PERSPECTIVE 153
Table 19: World Recent Past, Current & Future Analysis for
Blood Banking and Blood Products by Geographic Region - USA,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin
America and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through
2015 (includes corresponding Graph/Chart) 153
Table 20: World Historic Review for Blood Banking and Blood
Products by Geographic Region - USA, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2001 through 2006 (includes
corresponding Graph/Chart) 154
Table 21: World 10-Year Perspective for Blood Banking and
Blood Products by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets for
Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 155
Table 22: World Recent Past, Current & Future Analysis for
Blood Components and Plasma Products by Geographic Region -
USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 156
Table 23: World Historic Review for Blood Components and
Plasma Products by Geographic Region - USA, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2001 through 2006 (includes
corresponding Graph/Chart) 157
Table 24: World Recent Past, Current & Future Analysis for
Blood Components and Plasma Products by Product Group - Whole
Blood & Cellular Components, and Plasma Fractions Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 158
Table 25: World Historic Review for Blood Components and
Plasma Products by Product Group - Whole Blood & Cellular
Components, and Plasma Fractions Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2001 through 2006 (includes corresponding Graph/Chart) 159
Table 26: World 10-Year Perspective for Blood Components and
Plasma Products by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets for
Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 160
Table 27: World 10-Year Perspective for Blood Components and
Plasma Products by Product Segment - Percentage Breakdown of
Value Sales for Whole Blood & Cellular Components, and Plasma
Fractions Markets for Years 2005, 2010 & 2015 161
Table 28: World Recent Past, Current & Future Analysis for
Whole Blood & Cellular Components by Geographic Region - USA,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin
America and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through
2015 (includes corresponding Graph/Chart) 162
Table 29: World Historic Review for Whole Blood & Cellular
Components by Geographic Region - USA, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales in US$
Million for Years 2001 through 2006 (includes corresponding
Graph/Chart) 163
Table 30: World 10-Year Perspective for Whole Blood & Cellular
Components by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets for
Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 164
Table 31: World Recent Past, Current & Future Analysis for
Plasma Fractions by Geographic Region - USA, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 165
Table 32: World Historic Review for Plasma Fractions by
Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2001 through 2006 (includes corresponding
Graph/Chart) 166
Table 33: World 10-Year Perspective for Plasma Fractions by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2005, 2010 &
2015 (includes corresponding Graph/Chart) 167
Table 34: World Recent Past, Current & Future Analysis for
Equipment, Blood Tests and Other Consumables by Geographic
Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Latin America and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2007 through 2015 (includes corresponding Graph/Chart) 168
Table 35: World Historic Review for Equipment, Blood Tests
and Other Consumables by Geographic Region - USA, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Latin America
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2001 through 2006
(includes corresponding Graph/Chart) 169
Table 36: World 10-Year Perspective for Equipment, Blood
Tests and Other Consumables by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets for Years 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 170
17. THE UNITED STATES 171
A.Market Analysis 171
Current and Future Analysis 171
Market Trends 171
Recession Impacts Blood Bank Reserves 171
US Blood Collection & Supply Profile 171
Blood Group Distribution 172
Table 37: US Market for Blood Banking and Blood Products:
Percentage Break up of Blood Group by Rh Factor (includes
corresponding Graph/Chart) 172
Table 38: Percentage Break up of Rh Blood Types in the US
by Racial Group 173
Blood Donated and Transfused Every Year 173
Males Form the Major Chunk of Donors 173
Cost of Blood 173
SARS Scares: Blood Banks Feel the Heat 173
Blood and Blood Preparations: A Recent Past Review of Trade
Statistics 174
Table 39: US Blood and Blood Preparations Market (2006 &
2007): Major Import Sources by Country - Germany, UK,
Canada, Switzerland, Belgium and Others (In US$ Million)
(includes corresponding Graph/Chart) 174
Table 40: US Blood and Blood Preparations Market (2006 &
2007): Major Export Destinations by Country - Germany,
Netherlands, UK, Switzerland, Canada and Others (In US$
Million) (includes corresponding Graph/Chart) 174
US Blood Components and Plasma Market Analysis in Units 175
Table 41: US Recent Past, Current & Future Analysis for
Blood Components and Plasma by Product Category - Red Blood
Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets
Independently Analyzed with Annual Consumption in Million
Units for Years 2007 through 2015 (includes corresponding
Graph/Chart) 175
Table 42: US Historic Review for Blood Components and
Plasma by Product Category - Red Blood Cells (RBCs),
Platelets, and Fresh Frozen Plasma Markets Independently
Analyzed with Annual Consumption in Million Units for Years
2001 through 2006 (includes corresponding Graph/Chart) 175
Table 43: US 10-Year Perspective for Blood Components and
Plasma by Product Category - Percentage Breakdown of Volume
Consumption for Red Blood Cells (RBCs), Platelets, and
Fresh Frozen Plasma for Years 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 176
Regulations Control Plasma Collection Industry 176
B.Market Analytics 177
Table 44: US Recent Past, Current & Future Analysis for
Blood Banking and Blood Products by Product Group/ Segment -
Blood Components and Plasma Products (Whole Blood & Cellular
Components, and Plasma Fractions); and Equipment, Blood
Tests and Other Consumables Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 177
Table 45: US Historic Review for Blood Banking and Blood
Products by Product Group/Segment - Blood Components and
Plasma Products (Whole Blood and Cellular Components, and
Plasma Fractions); and Equipment, Blood Tests and Other
Consumables Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2001 through 2006 (includes
corresponding Graph/Chart) 178
Table 46: US 10-Year Perspective for Blood Banking and Blood
Products by Product Group/Segment - Percentage Breakdown of
Value Sales for Blood Components and Plasma Products (Whole
Blood & Cellular Components, and Plasma Fractions); and
Equipment, Blood Tests and Other Consumables Markets for
Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 179
18. CANADA 180
A.Market Analysis 180
Current and Future Analysis 180
Blood Facts 180
Bleeding Disorders - A Major Threat 180
The 'CSA-Z902-04' - A Comprehensive Voluntary Blood Safety
Standard 180
Blood and Blood Preparations: Import & Export Scenario in
the Recent Past 181
Table 47: Canadian Blood and Blood Preparations Market
(2006 & 2007): Major Import Sources by Country - US, The
Netherlands, Switzerland, Belgium, Italy and Others (In US$
Million) (includes corresponding Graph/Chart) 181
Table 48: Canadian Blood and Blood Preparations Market
(2006 & 2007): Major Export Destinations by Country - US,
France, Chile, Belgium, Germany and Others (In US$ Million)
(includes corresponding Graph/Chart) 181
B.Market Analytics 182
Table 49: Canadian Recent Past, Current & Future Analysis
for Blood Banking and Blood Products by Product
Group/Segment - Blood Components and Plasma Products (Whole
Blood & Cellular Components, and Plasma Fractions); and
Equipment, Blood Tests and Other Consumables Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 182
Table 50: Canadian Historic Review for Blood Banking and
Blood Products by Product Group/Segment - Blood Components
and Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions); and Equipment, Blood Tests and Other
Consumables Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2001 through 2006 (includes
corresponding Graph/Chart) 183
Table 51: Canadian 10-Year Perspective for Blood Banking and
Blood Products by Product Group/Segment - Percentage
Breakdown of Value Sales for Blood Components and Plasma
Products (Whole Blood & Cellular Components, and Plasma
Fractions); and Equipment, Blood Tests and Other Consumables
Markets for Years 2005, 2010 & 2015 (includes corresponding
Graph/Chart) 184
19. JAPAN 185
A.Market Analysis 185
Current and Future Analysis 185
Japan Witnesses Surge in Imported Blood Products 185
Growing Market for Fresh Frozen Plasma 185
Growing Use of Imported Albumin-Based Blood Products 185
The Goal of Self-Sufficiency 186
B.Market Analytics 187
Table 52: Japanese Recent Past, Current & Future Analysis
for Blood Banking and Blood Products by Product
Group/Segment - Blood Components and Plasma Products (Whole
Blood & Cellular Components, and Plasma Fractions); and
Equipment, Blood Tests and Other Consumables Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 187
Table 53: Japanese Historic Review for Blood Banking and
Blood Products by Product Group/Segment - Blood Components
and Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions); and Equipment, Blood Tests and Other
Consumables Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2001 through 2006 (includes
corresponding Graph/Chart) 188
Table 54: Japanese 10-Year Perspective for Blood Banking and
Blood Products by Product Group/Segment - Percentage
Breakdown of Value Sales for Blood Components and Plasma
Products (Whole Blood & Cellular Components, and Plasma
Fractions); and Equipment, Blood Tests and Other Consumables
Markets for Years 2005, 2010 & 2015 (includes corresponding
Graph/Chart) 189
20. EUROPE 190
A.Market Analysis 190
Current & Future Analysis 190
European Blood Banking and Blood Products Market at a
Glance (All figures are 2010 estimates & CAGR is for the
period 2007-2015) 190
Market Trends and Issues 190
Legislations on Payment for Donation Restrict Donors 190
Government's Check on Healthcare Costs Pressurizes BCT
Manufacturers 191
Purchasing System Witnesses Modifications 191
EU Nations Marching Towards Self-Sufficiency in Blood and
Blood Products 191
Blood Banking Devices Market 191
Table 55: European Recent Past, Current & Future Analysis
for Blood Banking Devices - Manual Blood Collection,
Apheresis, and Autologous Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 192
Table 56: European Historic Review for Blood Banking
Devices - Manual Blood Collection, Apheresis, and
Autologous Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2001 through 2006
(includes corresponding Graph/Chart) 193
Table 57: European 10-Year Perspective for Blood Banking
Devices by Product Segment - Manual Blood Collection,
Apheresis, and Autologous Devices Markets for Years 2005,
2010 & 2015 (includes corresponding Graph/Chart) 193
Table 58: European Blood Banking Devices Market (2007):
Percentage Breakdown of Value Sales by Geographic Region
for France, Germany, Italy, UK, Spain and Rest of Europe
(includes corresponding Graph/Chart) 194
A Snapshot of Health Care Systems Across Select EU Countries 194
France 194
Germany 194
Italy 195
The UK 195
Spain 195
B.Market Analytics 196
Table 59: European Recent Past, Current & Future Analysis
for Blood Banking and Blood Products by Geographic Region -
France, Germany, Italy, UK, Spain, Russia, and Rest of
Europe Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 196
Table 60: European Historic Review for Blood Banking and
Blood Products by Geographic Region - France, Germany,
Italy, UK, Spain, Russia, and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2001 through 2006 (includes corresponding
Graph/Chart) 197
Table 61: European Recent Past, Current & Future Analysis
for Blood Banking and Blood Products by Product Group/
Segment - Blood Components and Plasma Products (Whole Blood &
Cellular Components, and Plasma Fractions); and Equipment,
Blood Tests and Other Consumables Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2007 through 2015 (includes corresponding Graph/Chart) 198
Table 62: European Historic Review for Blood Banking and
Blood Products by Product Group/Segment - Blood Components
and Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions); and Equipment, Blood Tests and Other
Consumables Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2001 through 2006 (includes
corresponding Graph/Chart) 199
Table 63: European 10-Year Perspective for Blood Banking
and Blood Products by Geographic Region - Percentage
Breakdown of Value Sales for France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets for Years 2005,
2010 & 2015 (includes corresponding Graph/Chart) 200
Table 64: European 10-Year Perspective for Blood Banking and
Blood Products by Product Group/ Segment - Percentage
Breakdown of Value Sales for Blood Components and Plasma
Products (Whole Blood & Cellular Components, and Plasma
Fractions); and Equipment, Blood Tests and Other Consumables
Markets for Years 2005, 2010 & 2015 (includes corresponding
Graph/Chart) 201
20a. FRANCE 202
A.Market Analysis 202
Current and Future Analysis 202
B.Market Analytics 202
Table 65: French Recent Past, Current & Future Analysis for
Blood Banking and Blood Products by Product Group/ Segment -
Blood Components and Plasma Products (Whole Blood & Cellular
Components, and Plasma Fractions); and Equipment, Blood
Tests and Other Consumables Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 202
Table 66: French Historic Review for Blood Banking and Blood
Products by Product Group/Segment - Blood Components and
Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions); and Equipment, Blood Tests and Other
Consumables Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2001 through 2006 (includes
corresponding Graph/Chart) 203
Table 67: French 10-Year Perspective for Blood Banking and
Blood Products by Product Group/Segment - Percentage
Breakdown of Value Sales for Blood Components and Plasma
Products (Whole Blood & Cellular Components, and Plasma
Fractions); and Equipment, Blood Tests and Other Consumables
Markets for Years 2005, 2010 & 2015 (includes corresponding
Graph/Chart) 204
20b. GERMANY 205
A.Market Analysis 205
Current and Future Analysis 205
B.Market Analytics 205
Table 68: German Recent Past, Current & Future Analysis for
Blood Banking and Blood Products by Product Group/Segment -
Blood Components and Plasma Products (Whole Blood & Cellular
Components, and Plasma Fractions); and Equipment, Blood
Tests and Other Consumables Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 205
Table 69: German Historic Review for Blood Banking and Blood
Products by Product Group/Segment - Blood Components and
Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions); and Equipment, Blood Tests and Other
Consumables Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2001 through 2006 (includes
corresponding Graph/Chart) 206
Table 70: German 10-Year Perspective for Blood Banking and
Blood Products by Product Group/Segment - Percentage
Breakdown of Value Sales for Blood Components and Plasma
Products (Whole Blood & Cellular Components, and Plasma
Fractions); and Equipment, Blood Tests and Other Consumables
Markets for Years 2005, 2010 & 2015 (includes corresponding
Graph/Chart) 207
20c. ITALY
To order this report:
Blood Supply, Tissue Banking and Transplantation Industry: Global Blood Banking and Blood Products Industry
Blood Supply, Tissue Banking and Transplantation Business News
Check our Company Profile, SWOT and Revenue Analysis!
Contact Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article